Close

Analyst Ratings for KaloBios Pharmaceuticals (KBIO)

KBIO Rating Summary

  |   Expand Research on KBIO
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 7.5 / 10   Percentile Rank: 80%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/27/2014 JMP Securities N/A New Coverage Market Outperform
(N/A)
8.00
(N/A)
3.14
(2.19)
-30.25% Details
1/30/2014 Needham N/A Downgrade Hold
(Buy)
N/A
(N/A)
4.65
(2.19)
-52.9% Details